Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Pre-Close Trading Update

17 May 2017 07:00

RNS Number : 3487F
Ideagen PLC
17 May 2017
ย 

This announcement contains inside information.

ย 

ย 

17 May 2017

ย 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

ย 

Pre-Close Trading Update

ย 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2017 ahead of the announcement of its full year results on or around 18 July 2017.

ย 

The Board is pleased to report that results to 30 April 2017 are expected to be in line with market expectations and that trading was once again robust across all key verticals, with particular success within the Life Sciences, Aviation and Financial sectors. The Group delivered organic revenue growth* of approximately 10 per cent together with further contributions from all four acquisitions made during the year. This represents the Group's eighth consecutive year of revenue and adjusted EBITDA** growth.

ย 

The Group expects to report revenue of approximately ยฃ27.1million, (FY2016: ยฃ21.9 million) and adjusted EBITDA** of approximately ยฃ7.8 million (FY2016: ยฃ6.3 million), both having increased by approximately 24%, and a significant increase in adjusted EPS***, which continues to be an important financial metric for the Group.

ย 

The Board is confident that the transition from a traditional 'perpetual licence' business model to a 'subscription licence' model is well underway, as evidenced by a significant increase in the run-rate of recurring revenues. This has been driven primarily by the success of Coruson, our SaaS based enterprise Risk and Safety Management solution which is allowing the Group to win larger contracts and grow high visibility, subscription-based revenue.ย 

ย 

Cash generation was extremely strong at the end of the financial year and accordingly net cash at 30 April 2017 was significantly ahead of market forecasts at ยฃ4.2 million (31 October 2016: ยฃ4.8 million), even after paying ยฃ4.6 million of consideration for the acquisitions of IPI Solutions and Gael (deferred) and ยฃ0.3 million in dividends. The Board expects to report that cash generated by operations will be in excess of 100% of adjusted EBITDA**.

ย 

ย 

David Hornsby, Chief Executive, commented:ย "We are pleased to report that the Group has continued to perform well in delivering another year of high quality earnings growth underpinned by strong cash generation. We have also made four important acquisitions which have provided scale, product capability and recurring revenues. We continue to grow organically and to increase the percentage of our revenues derived from recurring business. The Group has significant contracted work in progress and a strong pipeline of new business opportunities which provides the Board with confidence for the current year and beyond."

ย 

* FY2016 comparator prepared on a proforma basis as if these acquisitions had occurred during that year

**Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and other exceptional items.

***Adjusted diluted earnings per share

ย 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

ย 

Graeme Spenceley, Finance Director

ย 

ย 

ย 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

ย 

Stephen Norcross (Corporate Broking)

ย 

ย 

ย 

ย 

ย 

ย About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visitย www.ideagen.com

ย 

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
TSTDQLFFDEFXBBK
Date   Source Headline
26th Jan 201610:43 amRNSDirector/PDMR Shareholding
26th Jan 20167:00 amRNSInterim Results
13th Jan 20161:41 pmRNSHolding(s) in Company
22nd Dec 20157:00 amRNSExercise of Options and Total Voting Rights
11th Dec 20159:53 amRNSHolding(s) in Company
25th Nov 20151:42 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSTrading Update
5th Nov 201511:23 amRNSChange of Registered Office Address
29th Oct 20153:59 pmRNSResult of AGM
20th Oct 20157:00 amRNSExercise of Options
7th Oct 20157:00 amRNSNotice of AGM
23rd Sep 20158:15 amRNSEnlighten product wins GRC Innovation Award
3rd Sep 20157:00 amRNSNew Contract Extensions worth £1m
10th Aug 20157:00 amRNSExercise of Options and Total Voting Rights
31st Jul 201511:54 amRNSDirector Dealing
23rd Jul 20157:00 amRNSGrant of Share Options
22nd Jul 20157:00 amRNSFinal Results
9th Jul 20157:00 amRNSNotice of Results
30th Jun 20159:19 amRNSShares Magazine Investor Event
3rd Jun 201511:25 amRNSHolding(s) in Company
21st May 20157:00 amRNSG-Cloud Award and New Contract Win
14th May 20157:00 amRNSPre-Close Trading Update
7th May 20157:00 amRNSExercise of Options and Total Voting Rights
30th Apr 201510:26 amRNSHolding(s) in Company
23rd Apr 201511:55 amRNSHolding(s) in Company
20th Apr 20152:53 pmRNSReplacement Director Dealing & Total Voting Rights
20th Apr 20157:00 amRNSDirector Dealing & Total Voting Rights
15th Apr 201511:25 amRNSHolding(s) in Company
11th Mar 201511:23 amRNSHolding(s) in Company
6th Mar 201512:57 pmRNSHolding(s) in Company
25th Feb 20157:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20157:00 amRNSNew Aviation Contract Wins worth £1m
29th Jan 20157:00 amRNSInterim Results
20th Jan 20153:41 pmRNSHolding(s) in Company
16th Jan 201512:44 pmRNSHolding(s) in Company
16th Jan 201512:42 pmRNSHolding(s) in Company
13th Jan 20151:04 pmRNSCompletion of Acquisition of Gael Limited
9th Jan 201511:55 amRNSHolding(s) in Company
7th Jan 201512:56 pmRNSResult of General Meeting
18th Dec 20147:00 amRNSAcquisition, Placing and Notice of General Meeting
13th Nov 20147:00 amRNSTrading update and Notice of Results
5th Nov 20148:30 amRNSIdeagen selected by NuGen
31st Oct 20141:47 pmRNSResult of AGM
9th Oct 20147:00 amRNSNotice of 2014 Annual General Meeting ("AGM")
2nd Oct 20147:00 amRNSContract Win and Trading Update
4th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20147:00 amRNSFinal Results
10th Jul 20147:00 amRNSNotice of Results
25th Jun 20147:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.